Danimer Scientific Announces Third Quarter 2024 Results
--Additional Resin Orders and Deliveries Continue to Support 20-Million Pound Cutlery Award –-
-- 100% Compostable Skittles® Bag Made with Nodax® PHA Featured at NFL Game --
“Our significant cutlery award continues to progress as we work toward the 20-million-pound annual run rate that we anticipate reaching in mid-2025. Consistent with the end customer’s ramp plan, we have received orders for over 250,000 pounds of cutlery resin and film resin to date. The end customer has invested significant capital in cutlery molds for each of our converter partners in support of the program scale-up and testing is proceeding well.
“We are excited about the soft launch of 100% compostable Skittles packaging made with our Nodax PHA resin. This packaging was featured at a Seattle Seahawks NFL game in
“While we remain focused on executing these commercial opportunities, we are mindful of managing our indebtedness levels and near-term constraints on liquidity as we enter our anticipated significant commercial ramp over the next twelve months. We are focused on preserving liquidity and analyzing a variety of transactions to strengthen our capital structure.”
Third Quarter 2024 Financial Highlights:
-
Revenues of
$8.6 million in the third quarter of 2024 were down by$2.3 million compared to revenue of$10.9 million in the third quarter of 2023. PHA revenue of$6.6 million decreased by$1.8 million in the quarter as compared with the prior year quarter. This was primarily due to the reapportionment of Starbucks’ straw business which led to significant disruptions in order patterns of the Company’s converter partners. PLA revenue of$1.3 million decreased by$0.6 million quarter-over-quarter, primarily due to decreased customer demand. -
Gross profit of
$(7.3) million was in line with$(7.7) million in the third quarter of 2023. Adjusted gross profitwas$(2.3) million compared to$(2.6) million in the third quarter of 2023. -
Net loss was
$(21.8) million in the third quarter of 2024 which improved as compared to$(40.2) million in the third quarter of 2023. -
Adjusted EBITDAwas
$(8.9) million in the third quarter of 2024 which improved as compared to$(9.3) million in the third quarter of 2023.
Capital Structure
At
The Company has taken actions to reduce its operating costs across all areas of the business, including reductions in discretionary spending, reduced labor costs through employee headcount rationalization, postponement of capital expenditures and the temporary suspension of operations at the Danimer Catalytic Technologies business. The Company has also heightened its focus on collections of accounts receivable and has launched an initiative to reduce on-hand inventory levels.
In light of the substantial leverage position, the Company continues to analyze a variety of transactions and mechanisms designed to reduce debt and/or provide additional liquidity.
Outlook
The Company reported third quarter results that were consistent with its expectations including the impact of the reapportionment related to the Starbucks straw resin business. As such, the Company is providing the following guidance for the remainder of the fiscal year:
-
Adjusted EBITDA through the third quarter is
($27.4) million . We expect fourth quarter Adjusted EBITDA to be in the range of($7.0) million to($7.5) million resulting in a full year Adjusted EBITDA total of($34.4) million to($34.9) million which is within the previously disclosed guidance range of$(30) million to$(35) million . -
We expect full-year capital expenditures will be between
$8 million and$9 million , within the previously disclosed guidance range of$8 million to$10 million . This range will support existing commitments related to theBainbridge greenfield facility, maintenance expenditures and other capital projects. - Given ongoing efforts to analyze a variety of transactions and mechanisms designed to provide additional liquidity, the Company is not providing a year-end liquidity outlook at this time.
Webcast, Conference Call and 10-Q Filing
The Company will host a webcast and conference call today,
About
Danimer is a pioneer in creating more sustainable, more natural ways to make plastic products. For more than a decade, its renewable and sustainable biopolymers have helped create plastic products that are biodegradable and compostable and return to nature instead of polluting our lands and waters. Danimer’s technology can be found in a vast array of plastic end products that people use every day. Applications for its biopolymers include additives, aqueous coatings, fibers, filaments, films and injection-molded articles, among others. Danimer holds more than 480 granted patents and pending patent applications in more than 20 countries for a range of manufacturing processes and biopolymer formulations. For more information, visit https://danimerscientific.com.
Forward Looking Statements
Please note that this press release may use words such as “appears,” “anticipates,” “believes,” “plans,” “expects,” “intends,” “future,” and similar expressions which constitute forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, without limitation, statements regarding expectations for the full year 2024 capital expenditures, Adjusted EBITDA and liquidity, and statements regarding expected PHA revenue growth. Forward-looking statements are made based on expectations and beliefs concerning future events impacting the Company and therefore involve a number of risks and uncertainties. The Company cautions that forward-looking statements are not guarantees and that actual results could differ materially from those expressed or implied in the forward-looking statements. Potential risks and uncertainties that could cause the actual results of operations or financial condition of the Company to differ materially from those expressed or implied by forward-looking statements in this release include, but are not limited to, the overall level of consumer demand on our products; our ability to maintain sufficient liquidity by realizing near-term revenue growth and related cash returns and preserving cash until such cash returns, if any are obtained; the effect on our borrowing facilities of an event of default, including if an Annual Report on Form 10-K contains a Report of Independent Registered Public Accounting Firm that includes disclosure regarding going concern; our ability to maintain our exchange listing; general economic conditions and other factors affecting consumer confidence, preferences, and behavior; disruption and volatility in the global currency, capital, and credit markets; the financial strength of the Company's customers; the Company's ability to implement its business strategy, including, but not limited to, its ability to expand its production facilities and plants to meet customer demand for its products and the timing thereof; risks relating to the uncertainty of the projected financial information with respect to the Company; the ability of the Company to execute and integrate acquisitions; changes in governmental regulation, legislation or public opinion relating to our products; the Company’s exposure to product liability or product warranty claims and other loss contingencies; the outcomes of any litigation matters; the impact on our business, operations and financial results from the ongoing conflicts in
|
||||||||
Condensed Consolidated Balance Sheets |
||||||||
|
|
|||||||
(in thousands, except share and per share data) |
2024 |
2023 |
||||||
Assets: | ||||||||
Current assets: | ||||||||
Cash and cash equivalents |
$ |
22,187 |
|
$ |
59,170 |
|
||
Accounts receivable, net |
|
11,745 |
|
|
15,227 |
|
||
Other receivables, net |
|
125 |
|
|
652 |
|
||
Inventories, net |
|
26,043 |
|
|
25,270 |
|
||
Prepaid expenses and other current assets |
|
5,395 |
|
|
4,714 |
|
||
Contract assets, net |
|
4,377 |
|
|
3,005 |
|
||
Total current assets |
|
69,872 |
|
|
108,038 |
|
||
Property, plant and equipment, net |
|
430,231 |
|
|
445,153 |
|
||
Intangible assets, net |
|
75,762 |
|
|
77,790 |
|
||
Right-of-use assets |
|
19,163 |
|
|
19,160 |
|
||
Leverage loans receivable |
|
31,446 |
|
|
31,446 |
|
||
Restricted cash |
|
14,116 |
|
|
14,334 |
|
||
Other assets |
|
3,180 |
|
|
2,210 |
|
||
Total assets |
$ |
643,770 |
|
$ |
698,131 |
|
||
Liabilities and Stockholders' Equity: | ||||||||
Current liabilities: | ||||||||
Accounts payable |
$ |
4,542 |
|
$ |
5,292 |
|
||
Accrued liabilities |
|
6,131 |
|
|
4,726 |
|
||
Unearned revenue and contract liabilities |
|
914 |
|
|
1,000 |
|
||
Current portion of lease liability |
|
3,724 |
|
|
3,337 |
|
||
Current portion of long-term debt, net |
|
6,021 |
|
|
1,368 |
|
||
Total current liabilities |
|
21,332 |
|
|
15,723 |
|
||
Long-term lease liability, net |
|
21,418 |
|
|
21,927 |
|
||
Long-term debt, net |
|
381,874 |
|
|
381,436 |
|
||
Warrant liability |
|
6,315 |
|
|
5 |
|
||
Other long-term liabilities |
|
1,238 |
|
|
1,020 |
|
||
Total liabilities |
$ |
432,177 |
|
$ |
420,111 |
|
||
Stockholders' equity: | ||||||||
Common stock, |
$ |
13 |
|
$ |
10 |
|
||
Additional paid-in capital |
|
737,464 |
|
|
732,131 |
|
||
Accumulated deficit |
|
(525,884 |
) |
|
(454,121 |
) |
||
Total stockholders’ equity |
|
211,593 |
|
|
278,020 |
|
||
Total liabilities and stockholders’ equity |
$ |
643,770 |
|
$ |
698,131 |
|
|
||||||||||||||||
Condensed Consolidated Statements of Operations |
||||||||||||||||
Three Months Ended |
Nine Months Ended |
|||||||||||||||
(in thousands, except share and per share data) |
2024 |
2023 |
2024 |
2023 |
||||||||||||
Revenue: | ||||||||||||||||
Products |
$ |
7,972 |
|
$ |
10,454 |
|
$ |
25,173 |
|
$ |
33,724 |
|
||||
Services |
|
658 |
|
|
494 |
|
|
1,309 |
|
|
2,015 |
|
||||
Total revenue |
|
8,630 |
|
|
10,948 |
|
|
26,482 |
|
|
35,739 |
|
||||
Costs and expenses: | ||||||||||||||||
Cost of revenue |
|
15,945 |
|
|
18,685 |
|
|
47,011 |
|
|
56,327 |
|
||||
Selling, general and administrative |
|
6,861 |
|
|
16,555 |
|
|
20,482 |
|
|
52,098 |
|
||||
Research and development |
|
4,580 |
|
|
6,883 |
|
|
15,031 |
|
|
21,667 |
|
||||
Loss on sale of assets |
|
65 |
|
|
64 |
|
|
630 |
|
|
234 |
|
||||
Total costs and expenses |
|
27,451 |
|
|
42,187 |
|
|
83,154 |
|
|
130,326 |
|
||||
Loss from operations |
|
(18,821 |
) |
|
(31,239 |
) |
|
(56,672 |
) |
|
(94,587 |
) |
||||
Nonoperating income (expense) | ||||||||||||||||
Gain (loss) on remeasurement of warrants |
|
(206 |
) |
|
132 |
|
|
5,635 |
|
|
99 |
|
||||
Interest, net |
|
(9,631 |
) |
|
(8,584 |
) |
|
(27,541 |
) |
|
(21,132 |
) |
||||
(Gain) loss on loan extinguishment |
|
6,821 |
|
|
- |
|
|
6,821 |
|
|
(102 |
) |
||||
Total nonoperating expense: |
|
(3,016 |
) |
|
(8,452 |
) |
|
(15,085 |
) |
|
(21,135 |
) |
||||
Loss before income taxes |
|
(21,837 |
) |
|
(39,691 |
) |
|
(71,757 |
) |
|
(115,722 |
) |
||||
Income taxes |
|
(2 |
) |
|
(468 |
) |
|
(6 |
) |
|
(317 |
) |
||||
Net loss |
$ |
(21,839 |
) |
$ |
(40,159 |
) |
$ |
(71,763 |
) |
$ |
(116,039 |
) |
||||
Basic net loss per share |
$ |
(0.18 |
) |
$ |
(0.39 |
) |
$ |
(0.63 |
) |
$ |
(1.14 |
) |
||||
Weighted average shares outstanding |
|
119,713,087 |
|
|
102,025,684 |
|
|
113,337,922 |
|
|
101,953,827 |
|
|
||||||||
Condensed Consolidated Statements of Cash Flows |
||||||||
Nine Months Ended | ||||||||
|
||||||||
(in thousands) |
2024 |
2023 |
||||||
Cash flows from operating activities: | ||||||||
Net loss |
$ |
(71,763 |
) |
$ |
(116,039 |
) |
||
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
Depreciation and amortization |
|
22,345 |
|
|
22,005 |
|
||
Gain on remeasurement of warrants |
|
(5,635 |
) |
|
(99 |
) |
||
Amortization of debt issuance costs |
|
8,951 |
|
|
6,209 |
|
||
Stock-based compensation |
|
1,693 |
|
|
42,227 |
|
||
Warrant issuance costs |
|
867 |
|
|
- |
|
||
Loss on disposal of assets |
|
630 |
|
|
234 |
|
||
Accounts receivable reserves |
|
610 |
|
|
(1,462 |
) |
||
Inventory reserves |
|
513 |
|
|
540 |
|
||
Amortization of right-of-use assets and lease liability |
|
(124 |
) |
|
(278 |
) |
||
(Gain) loss on loan extinguishment |
|
(6,821 |
) |
|
102 |
|
||
Deferred income taxes |
|
- |
|
|
(199 |
) |
||
Other |
|
- |
|
|
941 |
|
||
Changes in operating assets and liabilities: | ||||||||
Accounts receivable |
|
2,873 |
|
|
7,029 |
|
||
Other receivables |
|
528 |
|
|
555 |
|
||
Inventories, net |
|
(1,287 |
) |
|
5,475 |
|
||
Prepaid expenses and other current assets |
|
(239 |
) |
|
1,816 |
|
||
Contract assets |
|
(759 |
) |
|
(1,244 |
) |
||
Other assets |
|
76 |
|
|
(119 |
) |
||
Accounts payable |
|
(638 |
) |
|
(2,061 |
) |
||
Accrued liabilities |
|
1,588 |
|
|
1,893 |
|
||
Other long-term liabilities |
|
217 |
|
|
706 |
|
||
Unearned revenue and contract liabilities |
|
(85 |
) |
|
438 |
|
||
Net cash used in operating activities |
|
(46,460 |
) |
|
(31,331 |
) |
||
Cash flows from investing activities: | ||||||||
Purchases of property, plant and equipment and intangible assets |
|
(7,486 |
) |
|
(25,722 |
) |
||
Proceeds from disposals of property, plant and equipment |
|
1,167 |
|
|
18 |
|
||
Net cash used in investing activities |
|
(6,319 |
) |
|
(25,704 |
) |
||
Cash flows from financing activities: | ||||||||
Proceeds from issuance of warrants, net of issuance costs |
|
8,888 |
|
|
- |
|
||
Proceeds from issuance of common stock, net of issuance costs |
|
4,517 |
|
|
- |
|
||
Proceeds from long-term debt |
|
20,716 |
|
|
130,000 |
|
||
Principal payments on long-term debt |
|
(17,594 |
) |
|
(12,437 |
) |
||
Cash paid for debt issuance costs |
|
(1,097 |
) |
|
(33,296 |
) |
||
Proceeds from employee stock purchase plan |
|
176 |
|
|
282 |
|
||
Employee taxes related to stock-based compensation |
|
(28 |
) |
|
(61 |
) |
||
Net cash provided by financing activities |
|
15,578 |
|
|
84,488 |
|
||
Net (decrease) increase in cash and cash equivalents and restricted cash |
|
(37,201 |
) |
|
27,453 |
|
||
Cash and cash equivalents and restricted cash-beginning of period |
|
73,504 |
|
|
64,401 |
|
||
Cash and cash equivalents and restricted cash-end of period |
$ |
36,303 |
|
$ |
91,854 |
|
Non-GAAP Financial Measures
This press release includes the non-GAAP financial measures “Adjusted EBITDA”, “Adjusted gross profit” and "Adjusted gross margin". Danimer management views these metrics as a useful way to look at the performance of its operations between periods and to exclude decisions on capital investment and financing that might otherwise impact the review of profitability of the business based on present market conditions.
Adjusted EBITDA is defined as net income or loss plus net interest expense, income taxes, depreciation and amortization, as adjusted to add back certain charges or gains that Danimer may record each period such as remeasurement of warrants, stock-based compensation expense, as well as non-recurring charges such as (i) asset disposal gains or losses as well as other significant gains or losses such as debt extinguishments and impairment of goodwill; (ii) legal settlements; or (iii) other discrete non-recurring items. Danimer believes these items are not considered an indicator of ongoing performance. Adjusted EBITDA is not a measure of performance defined in accordance with GAAP. The measure is used as a supplement to GAAP results in evaluating certain aspects of Danimer’s business, as described below.
Adjusted gross profit is defined as gross profit plus depreciation, stock-based compensation and other nonrecurring items.
Adjusted gross margin is defined as adjusted gross profit divided by total revenue.
Danimer believes that each of Adjusted EBITDA, Adjusted gross profit and Adjusted gross margin is useful to investors in evaluating the Company’s performance because each measure considers the performance of the Company’s operations, excluding decisions made with respect to capital investment, financing and other non-recurring charges as outlined in the preceding paragraph. Danimer believes these non-GAAP metrics offer additional financial information that, when coupled with the GAAP results and the reconciliation to GAAP results, provides a more complete understanding of its results of operations and the factors and trends affecting its business.
Adjusted EBITDA, Adjusted gross profit and Adjusted gross margin should not be considered as an alternative to net income or loss as an indicator of its performance or as alternatives to any other measure prescribed by GAAP as there are limitations to using such non-GAAP measures. Although Danimer believes that Adjusted EBITDA, Adjusted gross profit and Adjusted gross margin may enhance an evaluation of its operating performance based on recent revenue generation and product/overhead cost control because it excludes the impact of prior decisions made about capital investment, financing and other expenses, (i) other companies in Danimer’s industry may define Adjusted EBITDA, Adjusted gross profit and Adjusted gross margin differently than Danimer does and, as a result, they may not be comparable to similarly titled measures used by other companies in its industry, and (ii) Adjusted EBITDA, Adjusted gross profit and Adjusted gross margin exclude certain financial information that some may consider important in evaluating Danimer’s performance.
Danimer compensates for these limitations by providing disclosure of the differences between Adjusted EBITDA, Adjusted gross profit and Adjusted gross margin and GAAP results, including providing a reconciliation to GAAP results, to enable investors to perform their own analysis of Danimer’s operating results. Because GAAP financial measures on a forward-looking basis are not accessible, and reconciling information is not available without unreasonable effort, reconciliations to GAAP financial measures are not provided for forward-looking non-GAAP measures. For the same reasons, the Company is unable to address the probable significance of the unavailable information, which could be material to future results.
|
||||||||
Reconciliation of Adjusted EBITDA to Net Loss (Unaudited) |
||||||||
Three Months Ended |
||||||||
2024 |
2023 |
|||||||
(in thousands) | ||||||||
Net loss |
$ |
(21,839 |
) |
$ |
(40,159 |
) |
||
Interest, net |
|
9,631 |
|
|
8,584 |
|
||
Depreciation and amortization |
|
7,376 |
|
|
7,253 |
|
||
(Gain) loss on loan extinguishment |
|
(6,821 |
) |
|
- |
|
||
Transaction and other related |
|
1,197 |
|
|
- |
|
||
Stock-based compensation |
|
744 |
|
|
14,324 |
|
||
Strategic reorganization and related |
|
522 |
|
|
382 |
|
||
Loss (gain) on remeasurement of warrants |
|
206 |
|
|
(132 |
) |
||
Litigation and other legal related |
|
101 |
|
|
28 |
|
||
Income taxes |
|
2 |
|
|
468 |
|
||
Adjusted EBITDA |
$ |
(8,881 |
) |
$ |
(9,252 |
) |
||
Reconciliation of Adjusted Gross Profit to Gross Profit (Unaudited) |
||||||||
Three Months Ended |
||||||||
2024 |
2023 |
|||||||
(in thousands) | ||||||||
Total revenue |
$ |
8,630 |
|
$ |
10,948 |
|
||
Cost of revenue |
|
15,945 |
|
|
18,685 |
|
||
Gross profit |
|
(7,315 |
) |
|
(7,737 |
) |
||
Depreciation |
|
5,049 |
|
|
5,086 |
|
||
Stock-based compensation |
|
3 |
|
|
2 |
|
||
Adjusted gross profit |
$ |
(2,263 |
) |
$ |
(2,649 |
) |
||
Adjusted gross margin |
|
(26.2 |
%) |
|
(24.2 |
%) |
View source version on businesswire.com: https://www.businesswire.com/news/home/20241119474813/en/
Investor Relations and Media
Phone: 770-337-6570
ir@danimer.com
Source: